Alpha-synuclein immunoreactive Lewy bodies and Lewy neurites in Parkinson's disease are detectable by an advanced silver-staining technique

Acta Neuropathologica

Volumn 98, Issue 5, 1999, Pages 461-464

  Sandmann Keil, Daniele ^a   Braak, Heiko ^a   Okochi, Masayasu ^b   Haass, Christian ^b   Braak, Eva ^a  

^a GOETHE UNIVERSITY   (Germany)

^b CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

Synuclein; Immunocytochemistry; Lewy body; Parkinson's disease; Silver staining

Indexed keywords

ALPHA SYNUCLEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; LEWY BODY; NEURITE; PARKINSON DISEASE; PRIORITY JOURNAL; SILVER STAINING; TECHNIQUE; TIME;

ALPHA-SYNUCLEIN; HUMANS; LEWY BODIES; NERVE TISSUE PROTEINS; PARKINSON DISEASE; SILVER STAINING; SYNUCLEINS;

EID: 0032855251     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004010051110     Document Type: Article

References (21)

1. Baba M, Nakajo S, Tu P-H, Tomita T, Nakaya K, Lee VM-Y, Trojanowski JQ, Iwatsubo T (1998) Aggregation of α-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. Am J Pathol 152: 879-884
2. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1: 213-216
3. Braak H, Braak E, Yilmazer D, Vos RAI de, Jansen ENH, Bohl J (1996) Pattern of brain destruction in Parkinson's and Alzheimer's diseases. J Neural Transm [PD Sect] 103: 455-490
4. Campbell SK, Switzer RC, Martin TL (1987) Alzheimer's plaques and tangles: a controlled and enhanced silver-staining method. Soc Neurosci Abstr 13: 678
5. Ciss S, Perry G, Lacoste-Royal G, Cabana T, Gauvreau D (1993) Immunochemical identification of ubiquitin and heat-shock proteins in corpora amylacea from normal aged and Alzheimer's disease brains. Acta Neuropathol 85: 233-240
6. Dickson DW, Schmidt ML, Lee VM, Zhao ML, Yen SH, Trojanowski JQ (1994) Immunoreactivity profile of hippocampal CA2/3 neuntes in diffuse Lewy body disease. Acta Neuropathol 87: 269-276
7. Gallyas F (1979) Light insensitive physical developers. Stain Technol 54: 173-176
8. Gibb WRG, Lees AJ (1989) The significance of the Lewy body in the diagnosis of idiopathic Parkinson's disease. Neuropathol Appl Neurobiol 15: 27-44
9. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 55: 181-184
10. Iqbal K, Braak H, Braak E, Grundke-Iqbal I (1993) Silver labeling of Alzheimer neuofibrillary changes and brain β-amyloid. J Histotechnol 16: 335-342
11. Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT (1998) Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain α-synuclein immunoreactivity. J Neuropathol Exp Neurol 57: 334-337
12. Jellinger K (1989) Pathology of Parkinson's disease. In: Calne DB (ed) Handbook of experimental pharmacology, vol 88. Drugs for the treatment of Parkinson's disease. Springer, Berlin Heidelberg New York, pp 47-112
13. Koller WC (1992) How accurately can Parkinson's disease be diagnosed? Neurology 42: 6-16
14. Lowe J (1994) Lewy bodies. In: Calne DB (ed) Neurodegenerative diseases. Saunders, Philadelphia, pp 51-69
15. Okochi M, Grünberg J, Leimer U, Capell A, Walter J, Farrer M, Duff K, Hardy J, Haass C (1998) Biochemical characterization of Parkinson's disease asssociated α-synuclein. Neurobiol Aging 19 [Suppl 2]: 52-53
16. Pollanen MS, Dickson DW, Bergeron C (1993) Pathology and biology of the Lewy body. J Neuropathol Exp Neurol 52: 183-191
17. Smithson KG, MacVicar BA, Hatton GI (1983) Polyethylene glycol embedding: a technique compatible with immunocytochemistry, enzyme histochemistry, histofluorescence and intracellular staining. J Neurosci Methods 7: 27-41
18. Spillantini MG, Schmidt ML, Lee VM-Y, Trojanowski JQ, Jakes R, Goedert M (1997) α-Synuclein in Lewy bodies. Nature 388: 839-840
19. Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E (1998) Abnormal accumulation of NACP/α-synuclein in neurodegenerative disorders. Am J Pathol 152: 367-372
20. Trojanowski JQ, Lee VM-Y (1998) Aggregation of neurofilament and alpha-synuclein proteins in Lewy bodies. Implications for the pathogenesis of Parkinson disease and Lewy body dementia. Arch Neurol 55: 151-152
21. Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H (1997) NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease. Neurosci Lett 239: 45-48